Researchers continue to excited about the medication , a groundbreaking dual agonist showing promising outcomes in clinical trials for body reduction . It functions by modulating two hormones : GLP-1 and GIP, which , when engaged , support regulate appetite and enhance metabolism . Initial observations indicate noteworthy body reduction and like… Read More